Emma M. Large
CN Bio Innovations (United Kingdom)(GB)
Publications by Year
Research Areas
3D Printing in Biomedical Research, Liver Disease Diagnosis and Treatment, Pharmacogenetics and Drug Metabolism, Growth Hormone and Insulin-like Growth Factors, Drug-Induced Hepatotoxicity and Protection
Most-Cited Works
- → 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection(2018)221 cited
- → Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk(2017)165 cited
- → Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease(2017)140 cited
- → Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor(2015)93 cited
- → Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System(2017)69 cited
- → Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxins(2017)34 cited
- → An investigation of insulin-like growth factor binding protein-5 (IGFBP-5) as a biomarker for the detection of early liver disease(2015)
- Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk(2017)
- → IGFBP-5 as a biomarker of de-differentiation in hepatocytes(2011)
- → Systems pharmacology guided platform development for the integrated Microphysiological Systems(2015)